Literature DB >> 2644098

Use of anticoagulants during pregnancy.

J S Ginsberg, J Hirsh.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2644098     DOI: 10.1378/chest.95.2_supplement.156s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  7 in total

Review 1.  Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Authors: 
Journal:  BMJ       Date:  1992-09-05

Review 2.  Treatment of a patient with an undefined hypercoagulable state with long-term low-molecular-weight heparin.

Authors:  S A Dobie; A J Ellsworth; M L Linenberger
Journal:  West J Med       Date:  1996-04

Review 3.  Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders.

Authors:  D R Anderson; L A Fernandez
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

Review 4.  Clinical utilization of the international normalized ratio (INR).

Authors:  R S Riley; D Rowe; L M Fisher
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 5.  Risk-benefit assessment of anticoagulant therapy.

Authors:  R Harrington; J Ansell
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 6.  Long-term anticoagulation. Indications and management.

Authors:  B M Stults; W H Dere; T H Caine
Journal:  West J Med       Date:  1989-10

7.  Fractionation of sulfated galactan from the red alga Botryocladia occidentalis separates its anticoagulant and anti-SARS-CoV-2 properties.

Authors:  Seon Beom Kim; Mary Zoepfl; Priyanka Samanta; Fuming Zhang; Ke Xia; Reena Thara; Robert J Linhardt; Robert J Doerksen; Michael A McVoy; Vitor H Pomin
Journal:  J Biol Chem       Date:  2022-03-23       Impact factor: 5.486

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.